THE PHARMACOKINETICS OF ASPIRIN IN RATS AND THE EFFECT OF BUFFER

被引:16
作者
FU, CJ
MELETHIL, S
MASON, WD
机构
[1] UNIV MISSOURI, SCH PHARM, PHARMACOKINET LAB, KANSAS CITY, MO 64108 USA
[2] UNIV MISSOURI, SCH MED, KANSAS CITY, MO 64108 USA
[3] KANSAS CITY ANALYT SERV, SHAWNEE, KS 66216 USA
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1991年 / 19卷 / 02期
关键词
ASPIRIN; RAT; PHARMACOKINETICS; EFFECT OF BUFFER;
D O I
10.1007/BF01073867
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aspirin (acetylsalicyclic acid) was administered to rats intravenously, orally, and intraintestinally at different doses or in different dosage forms. The distribution and elimination kinetics of aspirin in rats following intravenous administration were best described by a two-compartmental open system and were dose independent up to 15 mg/kg. The terminal elimination half-life following intravenous dosing (10 mg/kg) was 3.36 +/- 0.85 min (n = 15) with the clearance being 8.40 +/- 1.24 L/(kg.hr). Intravenous distribution and elimination kinetics of aspirin in rats were not influenced by an orally administered buffered solution with a buffer capacity of 0.933 mEq ANC (acid neutralizing capacity) per kg of body weight. However, this orally buffered solution did change the gastrointestinal absorption kinetics of aspirin in rats. The absolute bioavailable dose of aspirin was 56.6 +/- 10.4% (n = 6) following its administration in an unbuffered solution while it was only 31.8 +/- 8.0% (n = 6) following administration in the buffered solution. The corresponding values of the absolute bioavailable doses were 43.4 +/- 3.7% and 25.5 +/- 1.8% following intraintestinal administration. The lower systemic availability of aspirin in the presence of buffer is attributed to a greater fraction of the administered dose becoming available for absorption from the intestine where the extraction efficiency is higher than that in the stomach.
引用
收藏
页码:157 / 173
页数:17
相关论文
共 37 条
[1]   EFFECT OF WATER-DEPRIVATION ON ASPIRIN DISPOSITION KINETICS [J].
BAKAR, SK ;
NIAZI, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (09) :1030-1034
[2]  
BOLTON S, 1984, PHARM STAT, P130
[3]   STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].
BOXENBAU.HG ;
RIEGELMA.S ;
ELASHOFF, RM .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148
[4]  
Cooke A R, 1971, Guys Hosp Rep, V120, P221
[5]   ABSORPTION OF ACETYLSALICYLIC ACID FROM UNBUFFERED AND BUFFERED GASTRIC CONTENTS [J].
COOKE, AR .
AMERICAN JOURNAL OF DIGESTIVE DISEASES, 1970, 15 (02) :95-&
[6]  
DOTEVALL G, 1976, SCAND J GASTROENTERO, V11, P801
[7]   METHOD FOR DETERMINATION OF ASPIRIN AND SALICYLIC-ACID IN RAT WHOLE-BLOOD BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].
FU, CHJ ;
MELETHIL, S ;
MASON, WD .
ANALYTICAL LETTERS PART B-CLINICAL AND BIOCHEMICAL ANALYSIS, 1985, 18 (03) :269-277
[8]   INFLUENCE OF ROUTE OF ADMINISTRATION ON AREA UNDER PLASMA CONCENTRATION-TIME CURVE [J].
HARRIS, PA ;
RIEGELMA.S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (01) :71-&
[9]  
HOGBEN CAM, 1957, J PHARMACOL EXP THER, V120, P540
[10]  
HOGBEN CAM, 1959, J PHARMACOL EXP THER, V125, P275